中国药业2017，Vol.26Issue(23)：75-77,3.DOI:10.3969/j.issn.1006-4931.2017.23.025
1例利奈唑胺致药源性血小板减少症的药学监护
Pharmaceutical Care of 1 Patient with Linezolid-Induced Thrombocytopenia
邓英光 1张紫萍 1林茵 2郭秀彩1
作者信息
- 1. 广东省广州市第十二人民医院,广东广州 510620
- 2. 中山大学孙逸仙纪念医院,广东广州 510120
- 折叠
摘要
Abstract
Objective To investigate the role of clinical pharmacists in individualized drug use and medication monitoring of linezolid-induced thrombocytopenia. Methods The clinical data of 1 patient with pulmonary infection and drug-induced thrombocytopenia was analyzed, in order to judge the relationship between suspicious drugs and adverse drug reactions, and summarize the main points of implementation of pharmaceutical care. Results Thrombocytopenia was the severe adverse drug reaction induced by linezolid. The high risk factors were advanced age, long-term treatment, combined use of more than 3 kinds of antibiotics and renal insufficiency. Conclusion The clinical pharmacists participate in pharmaceutical care can promote more standardized and rational drug use in clinical, and better reflect individualized medication and medication monitoring.关键词
利奈唑胺/血小板减少症/临床药师/药学监护/药品不良反应Key words
linezolid/thrombocytopenia/clinical pharmacist/pharmaceutical care/adverse drug reaction分类
医药卫生引用本文复制引用
邓英光,张紫萍,林茵,郭秀彩..1例利奈唑胺致药源性血小板减少症的药学监护[J].中国药业,2017,26(23):75-77,3.
